miR-27a is up regulated and promotes inflammatory response in sepsis

Zhongchuan Wang1, Zhengshang Ruan2, Yanfei Mao2

  • 1Department of Colorectal Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China.

Cellular Immunology
|July 22, 2014
PubMed

Insights

MicroRNAs (miRNAs) regulate gene expression and are dysregulated in sepsis. This study shows miR-27a inhibition reduces sepsis-induced inflammation and improves survival in mice, highlighting its therapeutic potential.

Area of Science:

  • Molecular Biology
  • Immunology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are key regulators of gene expression.
  • miRNA dysregulation is implicated in the pathogenesis of sepsis.
  • Identifying specific miRNAs involved in sepsis is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the role of specific miRNAs in the pulmonary inflammatory response during sepsis.
  • To identify potential miRNA targets for sepsis treatment.

Main Methods:

  • MicroRNA microarray and quantitative real-time PCR (qRT-PCR) were used to profile miRNA expression in septic mouse lungs.
  • Functional studies involved knocking down miR-27a and neutralizing its activity.
  • Analysis included measuring levels of inflammatory cytokines (TNF-α, IL-6), NF-κB p65 phosphorylation, PPARγ expression, and assessing survival rates.

Main Results:

  • Several miRNAs were found to be differentially expressed in septic mouse lungs, with miR-27a, miR-153, and miR-143 upregulated, and let-7a, miR-218, and miR-129-5p downregulated.
  • Knockdown of miR-27a significantly reduced TNF-α and IL-6 levels by inhibiting NF-κB p65 phosphorylation and DNA binding.
  • Neutralization of miR-27a increased PPARγ, decreased TNF-α, alleviated pulmonary inflammation, and improved survival in septic mice.

Conclusions:

  • miR-27a plays a critical role in regulating the inflammatory response in sepsis.
  • Targeting miR-27a presents a promising therapeutic strategy for sepsis treatment.
  • Further research into miR-27a as a clinical target for sepsis is warranted.

Related Concept Videos

Acute Inflammation I: Inflammatory Response01:26

Acute Inflammation I: Inflammatory Response

Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect...
67
Acute Inflammation II: Local and Systemic Effects01:25

Acute Inflammation II: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
45
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
12.4K